US5032516A
(en)
*
|
1985-10-25 |
1991-07-16 |
Phillips Petroleum Company |
Pichia pastoris alcohol oxidase II regulatory region
|
US4895800A
(en)
*
|
1985-11-26 |
1990-01-23 |
Phillips Petroleum Company |
Yeast production of hepatitis B surface antigen
|
IL89993A0
(en)
*
|
1988-04-25 |
1989-12-15 |
Phillips Petroleum Co |
Expression of the hiv 24kda gag protein in methylotrophic yeasts
|
IL90021A0
(en)
*
|
1988-04-25 |
1989-12-15 |
Phillips Petroleum Co |
Process for the production of interferon
|
NZ228774A
(en)
*
|
1988-04-25 |
1991-05-28 |
Phillips Petroleum Co |
Hbv particles containing pres 2 proteins and recombinant processes for their production in yeast cells
|
IL89989A0
(en)
*
|
1988-04-25 |
1989-12-15 |
Phillips Petroleum Co |
Expression of human interleukin-2 in methylotrophic yeasts
|
IL89992A0
(en)
*
|
1988-04-25 |
1989-12-15 |
Phillips Petroleum Co |
Expression of human serum albumin in methylotrophic yeasts
|
AT390267B
(de)
*
|
1988-06-08 |
1990-04-10 |
Vogelbusch Gmbh |
Verfahren zum markieren und identifizieren von industriell eingesetzten mikroorganismen, vorzugsweise hefestaemmen
|
US5102789A
(en)
*
|
1989-03-15 |
1992-04-07 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Production of epideramal growth factor in pichia pastoris yeast cells
|
US5204252A
(en)
*
|
1989-02-08 |
1993-04-20 |
Henkel Research Corporation |
Candida tropicalis transformation system
|
DD297841A5
(de)
*
|
1989-02-13 |
1992-01-23 |
The Salk Institute Biotechnology/Industrial Associates,Us |
Herstellung von superoxiddismutase in pichia pastoris hefezellen
|
JPH0669365B2
(ja)
*
|
1989-05-22 |
1994-09-07 |
株式会社ミドリ十字 |
アルブミン遺伝子を含むプラスミド、形質転換体、形質転換体の製造方法、アルブミンの製造方法
|
CA2017176A1
(fr)
*
|
1989-05-22 |
1990-11-22 |
Yoshitomi Pharmaceutical Industries Ltd. |
Plasmide contenant le gene de l'albumine, bacteries receptrices les contenant, production de ces bacteries et production de l'albumine
|
US6440681B1
(en)
|
1990-04-03 |
2002-08-27 |
Merck & Co., Inc. |
Methods for identifying agonists and antagonists for human neuronal nicotinic acetylcholine receptors
|
US5369028A
(en)
*
|
1990-04-03 |
1994-11-29 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
|
US5258302A
(en)
*
|
1990-07-03 |
1993-11-02 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
DNA for expression of aprotinin in methylotrophic yeast cells
|
WO1992004363A1
(fr)
*
|
1990-09-04 |
1992-03-19 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Production du facteur-1 de croissance similaire a l'insuline dans des cellules de levure methylotrophique
|
US5612198A
(en)
*
|
1990-09-04 |
1997-03-18 |
The Salk Institute |
Production of insulin-like growth factor-1 in methylotrophic yeast cells
|
US5268273A
(en)
*
|
1990-12-14 |
1993-12-07 |
Phillips Petroleum Company |
Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same
|
WO1992013951A1
(fr)
*
|
1991-02-04 |
1992-08-20 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Production de serumalbumine humaine dans des cellules de levure methylotrophique
|
CA2063890C
(fr)
*
|
1991-03-27 |
2007-03-13 |
Masami Miura |
Promoteur aox2 mutant, microorganisme le renfermant, methode pour le preparer et production d'une proteine heterologue a l'aide de ce microorganisme
|
CA2105064A1
(fr)
*
|
1991-04-01 |
1992-10-02 |
Martin Anthony Gleeson |
Genes qui jouent un role dans l'activite proteolytique des especes du genre pichia et leur utilisation
|
CA2058820C
(fr)
*
|
1991-04-25 |
2003-07-15 |
Kotikanyad Sreekrishna |
Cassettes d'expression et vecteurs pour la secretion de serum albumine humaine dans des cellules pichia pastoris
|
US5330901A
(en)
*
|
1991-04-26 |
1994-07-19 |
Research Corporation Technologies, Inc. |
Expression of human serum albumin in Pichia pastoris
|
US5665600A
(en)
*
|
1991-09-18 |
1997-09-09 |
Research Corporation Technologies, Inc. |
Pichia pastoris linear plasmids and DNA fragments thereof
|
JP3541949B2
(ja)
*
|
1993-03-03 |
2004-07-14 |
ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン |
メチロトローフ酵母におけるグリコレートオキシダーゼの製造
|
WO1994020617A2
(fr)
*
|
1993-03-08 |
1994-09-15 |
The Salk Institute Biotechnology/Industrial Associates, Incorporated |
Compositions de recepteurs neuronaux humains de l'acetylcholine nicotinique et procedes faisant appel a ces compositions
|
ATE224952T1
(de)
*
|
1993-04-20 |
2002-10-15 |
Merck & Co Inc |
Untereinheiten von menschlichen n-methyl-d- aspartat rezeptoren, diese kodierende nukleinsäure und dessen verwendung
|
AU6831894A
(en)
*
|
1993-05-28 |
1994-12-20 |
E.I. Du Pont De Nemours And Company |
Process for preparing glyoxylic acid/dialkyl aminomethylphosphonate mixtures
|
US5912122A
(en)
|
1993-06-04 |
1999-06-15 |
Sibia Neurosciences, Inc. |
Nucleic acids encoding and method for detecting nucleic acid encoding human metabotropic glutamate receptor subtype mGluR6
|
US5521297A
(en)
|
1993-06-04 |
1996-05-28 |
Salk Institute Biotechnology/Industrial Associates |
Nucleic acids encoding human metabotropic glutamate receptors
|
US6001581A
(en)
*
|
1993-06-04 |
1999-12-14 |
Sibia Neurosciences, Inc. |
Cation-based bioassay using human metabotropic glutamate receptors
|
US6495343B1
(en)
|
1993-06-18 |
2002-12-17 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CRF receptor(s)
|
US6638905B2
(en)
|
1993-06-18 |
2003-10-28 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CFR receptor(s)
|
WO1995013299A1
(fr)
*
|
1993-11-08 |
1995-05-18 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Compositions de recepteurs neuronaux humains de l'acetylcholine nicotinique, et procedes faisant appel a celles-ci
|
NZ278490A
(en)
*
|
1993-12-09 |
1998-03-25 |
Univ Jefferson |
Chimeric polynucleotide with both ribo- and deoxyribonucleotides in one strand and deoxyribonucleotides in a second strand
|
US5866543A
(en)
*
|
1995-06-05 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
US5872098A
(en)
*
|
1995-06-05 |
1999-02-16 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
CA2202351A1
(fr)
*
|
1994-10-18 |
1996-04-25 |
George Phillip Vlasuk |
Proteines anticoagulantes et inhibiteurs de la serine-protease extraits de nematodes
|
US5945275A
(en)
*
|
1994-10-18 |
1999-08-31 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
PL183855B1
(pl)
|
1994-10-18 |
2002-07-31 |
Corvas International |
Białko, cząsteczka cDNA, oligonukleotyd, kompozycja farmaceutyczna i środek farmaceutyczny do hamowania krzepnięcia krwi
|
US5866542A
(en)
*
|
1994-10-18 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
US5863894A
(en)
*
|
1995-06-05 |
1999-01-26 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
AU715423B2
(en)
|
1995-03-17 |
2000-02-03 |
Novozymes A/S |
Novel endoglucanases
|
US6485967B1
(en)
|
1995-06-07 |
2002-11-26 |
Merck & Co., Inc. |
Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
|
WO1997014786A1
(fr)
*
|
1995-10-18 |
1997-04-24 |
New York Blood Center, Inc. |
α-N-ACETYLGALACTOSAMINIDASE RECOMBINEE
|
CA2237120C
(fr)
*
|
1995-11-09 |
2005-03-01 |
Zymogenetics, Inc. |
Compositions et procedes de production de polypeptides heterologues sur pichia methanolica
|
US6001597A
(en)
*
|
1995-11-09 |
1999-12-14 |
Zymogenetics, Inc. |
Compositions and methods for producing heterologous polypeptides in Pichia methanolica
|
DE69717092T2
(de)
|
1996-03-01 |
2003-07-24 |
Novo Nordisk As |
Gebrauch einer pharmazeutischen Zusammensetzung, enthaltend ein appetitzügelndes Peptid
|
US5731181A
(en)
*
|
1996-06-17 |
1998-03-24 |
Thomas Jefferson University |
Chimeric mutational vectors having non-natural nucleotides
|
WO1998016644A1
(fr)
|
1996-10-16 |
1998-04-23 |
Zymogenetics, Inc. |
Homologues de facteur de croissance fibroblastes (fgf)
|
MX9605082A
(es)
|
1996-10-24 |
1998-04-30 |
Univ Autonoma De Nuevo Leon |
Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
|
BR9913942A
(pt)
|
1998-09-23 |
2001-10-16 |
Zymogenetics Inc |
Polinucleotìdeo e polipeptìdeo isolado, vetor de expressão, célula cultivada, constructo de dna codificador de uma proteìna de fusão, processos de produção de uma proteìna, de fusão de um polipeptìdeo e de um anticorpo para o polipeptìdeo e de detecção, em uma amostra de teste, da presença de um modulador da atividade da proteìna zalpha11 e de um ligante de receptor zalpha11 dentro de uma amostra de teste, e, anticorpo
|
CA2354325C
(fr)
|
1998-12-07 |
2011-08-16 |
Zymogenetics, Inc. |
Zvegf3 homologue du facteur de croissance
|
US6780615B1
(en)
|
1998-12-31 |
2004-08-24 |
Genway Biotech Inc. |
Production of recombinant monellin using methylotrophic yeast expression system
|
PL393286A1
(pl)
|
1999-01-07 |
2011-06-06 |
Zymogenetics, Inc. |
Rozpuszczalny receptor BR43x2 i sposoby jego zastosowania
|
US7833529B1
(en)
|
1999-01-07 |
2010-11-16 |
Zymogenetics, Inc. |
Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
|
CN101575377B
(zh)
|
1999-03-09 |
2012-12-26 |
津莫吉尼蒂克斯公司 |
作为zalpha受体之配体的人细胞因子及其用途
|
US7504253B2
(en)
*
|
1999-06-11 |
2009-03-17 |
The Burnham Institute For Medical Research |
Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof
|
ATE508193T1
(de)
|
1999-07-07 |
2011-05-15 |
Zymogenetics Inc |
Menschliches rezeptor für zytokine
|
CA2395369C
(fr)
|
1999-12-23 |
2014-07-08 |
Zymogenetics, Inc. |
Cytokine zcyto18
|
WO2001087933A2
(fr)
|
2000-05-11 |
2001-11-22 |
Zymogenetics, Inc. |
Peptides de type zsig33
|
CA2412239C
(fr)
|
2000-06-26 |
2013-05-28 |
Zymogenetics, Inc. |
Zcytor17, recepteur de la cytokine
|
US7449308B2
(en)
*
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
ATE440959T1
(de)
*
|
2000-06-28 |
2009-09-15 |
Glycofi Inc |
Verfahren für die herstellung modifizierter glykoproteine
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
US7863020B2
(en)
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
CN100448993C
(zh)
|
2000-06-30 |
2009-01-07 |
津莫吉尼蒂克斯公司 |
干扰素样蛋白质Zcyto21
|
US6803225B2
(en)
|
2000-06-30 |
2004-10-12 |
Flanders Interuniversity Institute For Biotechnology |
Protein glycosylation modification in Pichia pastoris
|
US7009045B2
(en)
*
|
2000-07-14 |
2006-03-07 |
Archer-Daniels-Midland Company |
Transformation systems for flavinogenic yeast
|
EP1736545A3
(fr)
|
2000-08-08 |
2007-03-28 |
ZymoGenetics, Inc. |
Récepteurs de cytokines zcytor 11 solubles
|
JP2004533997A
(ja)
|
2001-02-20 |
2004-11-11 |
ザイモジェネティクス,インコーポレイティド |
Bcma及びtaciの両者を結合する抗体
|
ES2432967T3
(es)
|
2001-03-22 |
2013-12-05 |
Novo Nordisk Health Care Ag |
Derivados del Factor VII de coagulación
|
JP2005514001A
(ja)
|
2001-04-05 |
2005-05-19 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ |
酵母中での異種遺伝子発現のためのアルコールオキシダーゼ1調節ヌクレオチド配列
|
EA007275B1
(ru)
|
2001-05-24 |
2006-08-25 |
Займодженетикс, Инк. |
Слитые белки taci-иммуноглобулина
|
US6929932B2
(en)
|
2001-11-05 |
2005-08-16 |
Zymogenetics, Inc. |
IL-21 antagonists
|
WO2003054155A2
(fr)
*
|
2001-12-19 |
2003-07-03 |
Bristol-Myers Squibb Company |
Pichia pastoris formate deshydrogenase et ses utilisations
|
US7064186B2
(en)
|
2002-01-18 |
2006-06-20 |
Zymogenetics, Inc. |
Cytokine zcytor17 ligand
|
EP1576112B1
(fr)
|
2002-01-18 |
2012-02-29 |
ZymoGenetics, Inc. |
Recepteurs multimeres des cytokines contenant zcytor17
|
WO2003089589A2
(fr)
*
|
2002-04-15 |
2003-10-30 |
Merck & Co., Inc. |
Analyse matricielle d'expression genique dans des cellules
|
ES2356307T3
(es)
|
2002-04-19 |
2011-04-06 |
Zymogenetics, L.L.C. |
Procedimientos para detectar o modular la interacción de un receptor de citocina con su ligando.
|
US7252933B2
(en)
|
2002-06-26 |
2007-08-07 |
Flanders Interuniversity Institute For Biotechnology |
Protein glycosylation modification in methylotrophic yeast
|
DE60335602D1
(de)
*
|
2002-12-18 |
2011-02-17 |
Roche Diagnostics Gmbh |
Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
|
DE60319333D1
(de)
*
|
2002-12-20 |
2008-04-10 |
Roche Diagnostics Gmbh |
Hitzelabile Desoxyribonuklease I-Varianten
|
US7332299B2
(en)
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
EP1460425A1
(fr)
*
|
2003-03-17 |
2004-09-22 |
Boehringer Mannheim Gmbh |
Enzymes déglycosylés pour conjugués
|
ES2303132T3
(es)
|
2003-08-07 |
2008-08-01 |
Zymogenetics, Inc. |
Preparaciones homogeneas de il-29.
|
CN101870729A
(zh)
|
2003-09-09 |
2010-10-27 |
诺和诺德医疗保健公司 |
凝固因子ⅶ多肽
|
ES2337684T3
(es)
*
|
2003-12-05 |
2010-04-28 |
F. Hoffmann-La Roche Ag |
Carboxipeptidasa b recombinante y su purificacion.
|
JP2007521823A
(ja)
|
2004-02-13 |
2007-08-09 |
ノボザイムス アクティーゼルスカブ |
プロテアーゼ変異型
|
US7381794B2
(en)
|
2004-03-08 |
2008-06-03 |
Zymogenetics, Inc. |
Dimeric fusion proteins and materials and methods for producing them
|
JP2008508310A
(ja)
|
2004-07-29 |
2008-03-21 |
ザイモジェネティクス, インコーポレイテッド |
がんおよび自己免疫障害を治療するためのil−28およびil−29の使用法
|
EP2163635B1
(fr)
|
2004-08-02 |
2013-05-22 |
BASF Plant Science GmbH |
Procédé d'isolation de séquence de terminaison de transcription
|
EP1856156A2
(fr)
|
2005-02-08 |
2007-11-21 |
ZymoGenetics, Inc. |
Anticorps et partenaires de liaison anti-il-20, anti-il-22 et anti-il-22ra, et methodes d'utilisation de ces anticorps et partenaires de liaison dans des processus inflammatoires
|
KR20080013878A
(ko)
|
2005-04-18 |
2008-02-13 |
노보 노르디스크 에이/에스 |
Il-21 변이체
|
ES2772674T3
(es)
|
2005-05-12 |
2020-07-08 |
Zymogenetics Inc |
Composiciones y métodos para modular respuestas inmunitarias
|
WO2006130657A2
(fr)
*
|
2005-05-31 |
2006-12-07 |
Bristol-Myers Squibb Company |
Procede de reduction stereoselective pour la preparation de composes de pyrrolotriazine
|
WO2007019573A2
(fr)
|
2005-08-09 |
2007-02-15 |
Zymogenetics, Inc. |
Procedes pour le traitement et la prevention de proliferation cellulaire anormale par le biais de molecules de fusion taci
|
KR20080056714A
(ko)
*
|
2005-08-09 |
2008-06-23 |
지모제넥틱스, 인코포레이티드 |
TACI―Ig 융합 분자를 사용하여 B―세포 악성종양을치료하는 방법
|
JP5366546B2
(ja)
|
2005-08-16 |
2013-12-11 |
ノボ・ノルデイスク・エー/エス |
成熟インスリンポリペプチドの作製方法
|
CA2621344C
(fr)
*
|
2005-09-14 |
2014-12-16 |
Sanofi-Aventis Deutschland Gmbh |
Clivage de precurseurs d'insulines par un variant de la trypsine
|
US20090055942A1
(en)
|
2005-09-14 |
2009-02-26 |
Novo Nordisk Healthcare A/G |
Human Coagulation Factor VII Polypeptides
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
DE602006016965D1
(de)
|
2005-09-28 |
2010-10-28 |
Zymogenetics Inc |
Il-17a- und il-17f-antagonisten und verwendungsverfahren
|
BRPI0711823A2
(pt)
*
|
2006-05-15 |
2012-01-17 |
Ares Trading Sa |
métodos para tratamento de doenças auto-imunes com uma molécula de fusão taci-ig
|
US8518668B2
(en)
|
2006-09-27 |
2013-08-27 |
Novo Nordisk A/S |
Method for making maturated insulin polypeptides in a fungal cell
|
CA2682578C
(fr)
|
2007-04-03 |
2015-05-26 |
Oxyrane Uk Limited |
Glycosylation de molecules
|
US20100240597A1
(en)
|
2007-06-15 |
2010-09-23 |
Arkansas State University |
Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same
|
AU2008328371B2
(en)
|
2007-11-21 |
2011-08-11 |
Roskilde Universitet |
Polypeptides comprising an ice-binding activity
|
US20110027337A1
(en)
*
|
2007-12-21 |
2011-02-03 |
Ifxa A/S |
Protease inhibitor
|
DK2245052T3
(en)
*
|
2008-01-25 |
2017-09-11 |
Univ Aarhus |
SELECTIVE EXOSITE INHIBITATION OF PAPP-A ACTIVITY AGAINST IGFBP-4
|
SG188846A1
(en)
*
|
2008-03-03 |
2013-04-30 |
Abbott Lab |
Methods for transforming yeast
|
ES2456296T3
(es)
|
2008-03-27 |
2014-04-21 |
Zymogenetics, Inc. |
Composiciones y procedimientos para inhibir PDGFR beta y VEGF-A
|
US20110081698A1
(en)
*
|
2008-05-14 |
2011-04-07 |
Bio-Energay Corporation |
Method and introduction of gene into yeast cell, and vector for the method
|
US8658766B2
(en)
|
2008-06-27 |
2014-02-25 |
Zymogenetics, Inc. |
Soluble hybrid Fcγ receptors and related methods
|
US20110275535A1
(en)
|
2008-12-16 |
2011-11-10 |
Novartis Ag |
Yeast Display Systems
|
US8716448B2
(en)
|
2009-02-03 |
2014-05-06 |
Amunix Operating Inc. |
Coagulation factor VII compositions and methods of making and using same
|
BR122021021381B1
(pt)
|
2009-02-03 |
2023-05-16 |
Amunix Pharmaceuticals, Inc |
Método de aprimoramento de uma propriedade de uma proteína biologicamente ativa
|
EP2406282A1
(fr)
|
2009-03-11 |
2012-01-18 |
Novo Nordisk A/S |
Variants de l'interleukine 21 se liant de manière antagoniste au récepteur de l'il-21
|
CN107513103A
(zh)
|
2009-07-17 |
2017-12-26 |
丹麦国家医院 |
作为补体激活的抑制剂的masp同种型
|
JP5990102B2
(ja)
|
2009-09-29 |
2016-09-07 |
ユニフェルシテイト ヘント |
ホスホ−6−マンノースへのマンノース−1−ホスホ−6−マンノース結合の加水分解
|
DK2501805T3
(en)
|
2009-11-19 |
2019-04-15 |
Oxyrane Uk Ltd |
Yeast strains producing mammalian-like complex N-Glycans
|
ES2550761T3
(es)
|
2009-11-25 |
2015-11-12 |
Novo Nordisk A/S |
Método para producción de polipéptidos
|
CN102666570B
(zh)
|
2009-12-01 |
2015-12-02 |
诺沃—诺迪斯克有限公司 |
新的肽基α-羟基甘氨酸α-酰胺化裂合酶
|
EP3815708A1
(fr)
|
2010-03-05 |
2021-05-05 |
Omeros Corporation |
Molécules chimères inhibitrices de l'activation du complément
|
US8822642B2
(en)
|
2010-06-09 |
2014-09-02 |
Zymogenetics, Inc. |
Dimeric fusion proteins and related compositions and methods
|
SG189110A1
(en)
|
2010-09-29 |
2013-05-31 |
Oxyrane Uk Ltd |
De-mannosylation of phosphorylated n-glycans
|
KR101983572B1
(ko)
|
2010-09-29 |
2019-05-29 |
옥시레인 유케이 리미티드 |
만노스-1-포스포-6-만노스 결합의 캡핑제거 및 인산화 n-글리칸의 탈만노실이 가능한 만노시다제 및 당단백질의 활용을 통한 포유류 세포의 촉진방법
|
EP2798074A1
(fr)
|
2011-12-30 |
2014-11-05 |
Oxyrane UK Limited |
Procédés et des matériels de réduction de la dégradation de protéines recombinantes
|
SG10201606285YA
(en)
|
2012-02-01 |
2016-09-29 |
Synthetic Genomics Inc |
Materials and methods for the synthesis of error-minimized nucleic acid molecules
|
US11787844B2
(en)
|
2012-02-09 |
2023-10-17 |
Var2 Pharmaceuticals Aps |
Targeting of chondroitin sulfate glycans
|
HUE060629T2
(hu)
|
2012-02-15 |
2023-03-28 |
Bioverativ Therapeutics Inc |
VIII. faktor készítmények és eljárások elõállításukra és alkalmazásukra
|
AU2013204636B2
(en)
|
2012-02-15 |
2016-04-14 |
Bioverativ Therapeutics Inc. |
Recombinant Factor VIII proteins
|
BR112014022624A2
(pt)
|
2012-03-15 |
2017-07-11 |
Oxyrane Uk Ltd |
métodos e materiais para tratamento de doença de pompe
|
KR101958234B1
(ko)
*
|
2012-05-09 |
2019-03-14 |
엘지이노텍 주식회사 |
보이스 코일 모터
|
EP2906693A1
(fr)
|
2012-10-15 |
2015-08-19 |
Novo Nordisk Health Care AG |
Polypeptides de facteur vii de coagulation
|
EP2964758B1
(fr)
|
2013-03-05 |
2020-05-27 |
Oxyrane UK Limited |
Production de sulfatase de type i catalytiquement active
|
BR112015023447A2
(pt)
|
2013-03-21 |
2017-12-05 |
Commw Scient Ind Res Org |
purificação de proteínas helicoidais triplas
|
CN105308067B
(zh)
|
2013-06-07 |
2020-07-24 |
诺和诺德股份有限公司 |
制备成熟胰岛素多肽的方法
|
WO2014202089A2
(fr)
|
2013-06-18 |
2014-12-24 |
Roskilde Universitet |
Variants de polypeptides antigel
|
US10548953B2
(en)
|
2013-08-14 |
2020-02-04 |
Bioverativ Therapeutics Inc. |
Factor VIII-XTEN fusions and uses thereof
|
TWI738631B
(zh)
|
2013-09-09 |
2021-09-11 |
德商贏創運營有限公司 |
經修飾之細菌類膠原蛋白蛋白質
|
ES2897639T3
(es)
*
|
2014-07-30 |
2022-03-02 |
Daiichi Sankyo Co Ltd |
Método para la producción secretora de alto nivel mejorada de proteínas
|
UA126016C2
(uk)
|
2015-08-03 |
2022-08-03 |
Біовератів Терапеутікс Інк. |
Злитий білок фактора іх
|
KR102440820B1
(ko)
|
2015-09-08 |
2022-09-05 |
테리피온, 인크. |
ApoA-1 융합 폴리펩티드 및 관련 조성물 및 방법
|
WO2018136163A2
(fr)
|
2016-12-09 |
2018-07-26 |
Theripion, Inc. |
Polypeptides de fusion apoa-1 en tandem
|
JP7012663B2
(ja)
*
|
2016-12-15 |
2022-02-14 |
株式会社カネカ |
新規宿主細胞及びそれを用いた目的タンパク質の製造方法
|
BR112020001180A2
(pt)
|
2017-07-20 |
2020-09-08 |
Aptevo Research And Development Llc |
proteínas de ligação a antígenos que se ligam a 5t4 e 4-1bb e composições e métodos relacionados
|
DK3710484T3
(da)
|
2017-12-20 |
2023-11-27 |
Harbour Biomed Shanghai Co Ltd |
Ctla-4-bindende antistoffer og anvendelser deraf
|
US10150801B1
(en)
|
2017-12-27 |
2018-12-11 |
Imunami Laboratories Pte. Ltd. |
Recombinant polypeptides and methods of use thereof
|
EP3732190A1
(fr)
|
2017-12-27 |
2020-11-04 |
Imunami Laboratories Pte. Ltd. |
Polypeptides recombinants et leurs procédés d'utilisation
|
DE202019005554U1
(de)
*
|
2018-03-06 |
2021-01-18 |
Joywell Foods, Inc. |
Rekombinant exprimierte geschmacksmodifizierende Polypeptide und Präparate und Formulierungen, die diese enthalten
|
EP3821244A1
(fr)
|
2018-07-13 |
2021-05-19 |
Varct Diagnostics ApS |
Isolement de cellules circulantes d'origine foetale à l'aide d'une protéine de malaria recombinante var2csa
|
CN111378585B
(zh)
*
|
2018-12-28 |
2023-06-16 |
丰益(上海)生物技术研发中心有限公司 |
用于表达外源基因的毕赤酵母突变株
|
US10675332B1
(en)
|
2019-08-26 |
2020-06-09 |
Imunami Laboratories Pte. Ltd. |
Recombinant polypeptides and methods of use thereof
|
EP4021512A1
(fr)
|
2019-08-26 |
2022-07-06 |
Imunami Laboratories Pte. Ltd. |
Polypeptides recombinants et leurs méthodes d'utilisation
|
JP2023538476A
(ja)
|
2020-06-22 |
2023-09-08 |
イミュナミ ラボラトリーズ プライベート リミティド |
癌治療における使用のための組換えポリペプチド及び組合せ
|
CA3207134A1
(fr)
|
2021-02-19 |
2022-08-25 |
Jeffrey A. Ledbetter |
Polypeptides de fusion dnase, compositions et methodes associees
|